Effect of empagliflozin on albuminuria, eGFR and serum creatinine: updated results from the ABCD nationwide empagliflozin audit

Effect of empagliflozin on albuminuria, eGFR and serum creatinine: updated results from the ABCD national empagliflozin audit. Thomas SJ Crabtree¹, Alex Bickerton², Jackie Elliot³, Rajeev Raghavan⁴, Dennis Barnes⁵, Siva Sivappriyan⁶, Suzanne Phillips⁷, Alison Evans⁷, Devesh Sennik⁸, Anurita Rohilla⁹, Ian Gallen¹⁰, Robert EJ Ryder¹¹ on behalf of the  ABCD Empagliflozin Audit Contributors. British Journal of Diabetes Vol 21 14/04/2021

https://bjd-abcd.com/index.php/bjd/article/view/629/951

1 University Hospitals of Derby and Burton NHS Trust; University of Nottingham; Sandwell and West Birmingham Hospitals NHS Trust, UK

2 Yeovil District Hospital NHS Trust, Somerset, UK

3 Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK

4 Wolverhampton Diabetes Centre, New Cross Hospital, Wolverhampton,UK

5 The Tunbridge Wells Hospital, Kent, UK

6 Maidstone Hospital, Kent, UK

7 Cheltenham General Hospital, Cheltenham, UK

8 Princess Alexandra Hospital, Harlow, UK

9 Chief Pharmacist, West Essex CCG, UK

10 Royal Berkshire NHS Foundation Trust, UK

11 City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, UK